Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation-Reference-Cited by-同舟云学术

Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation

Published:1994-03 Issue:6 Volume:47 Page:1029-1037
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Kocan Geralyn P.,Partis Richard A.,Mueller Richard A.,Smith Walter G.,Nakao Akira

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference41 articles.

1. Leukotrienes and other products of the 5-lipoxygenase pathway;Lewis;N Engl J Med,1990

2. Arachidonic acid metabolism;Holtzman;Am Rev Respir Dis,1991

3. Generation and recognition of leukotriene mediators of hypersensitivity and inflammation;Goetzel;Dig Dis Sci,1988

4. Leukotrienes and lipoxins: Structures, biosynthesis and biological effects;Samuelsson;Science,1987

5. Leukotriene B4 induced hyperadhesiviness of endothelial cells for neutrophils;Palmblad;Biochem Biophys Res Commun,1990

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased cytosol Ca2+ and type 1 programmed cell death in Bcl-2-positive U937 but not in Bcl-2-negative PC-3 and Panc-1 cells induced by the 5-lipoxygenase inhibitor MK 886;Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA);2002-04

2. Impact of MK-886 on H2O2 generation by human neutrophils and cell degranulation;Biochemistry (Moscow);2001

3. Five-Lipoxygenase Inhibitors Reduce Panc-1 Survival: Synergism of MK886 with Gamma Linolenic Acid;Advances in Experimental Medicine and Biology;1999

4. 5-lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death;The Prostate;1998-11-01

5. Inhibition of cancer cell proliferation by disruption of interdigitated/concatenated hierarchies of metabolic control/implementation processes: a proposal;Medical Hypotheses;1998-02